ISPRKIn Situ Perfused Rat Kidney
References in periodicals archive ?
In June of this year, the company announced preliminary results of the ISPRK study for myopia using the ISL picosecond Nd:YLF laser in a group of 10 non-sighted volunteers.
As announced earlier this week, the company reported that it had completed the patient-treatment portion of the Phase I study of ISPRK for the correction of nearsightedness.